In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lianluo Smart Limited

Latest From Lianluo Smart Limited

Vision And Resilience, The Hallmarks Of Axel Hoos’ Leadership Approach

Axel Hoos helped create the field of immuno-oncology and now has his sights on proving the worth of Scorpion Therapeutics’ precision oncology platform. The executive spoke with In Vivo about company culture, the Scorpion strategy and resilience in the face of resistance. 

Leadership Innovation

Pierre Fabre Continues Oncology R&D Push

The French firm has followed up its recent acquisition of Swiss lung cancer specialist Vertical Bio by signing a pact with Vernalis.

Cancer M & A

Deal Watch: Moderna, Immactics Team Up To Combine mRNA Technology With Cancer Cell Therapy

Plus deals involving Kelun Biotech, Pierre Fabre/Vertical, Novo Nordisk/Broad Institute, ABL Bio/Synaffix, Kriya/Tramontane, Palisade/Giiant and more.

Deal Watch Business Strategies

Scorpion Partners Two Assets With Pierre Fabre To Prioritize Investment In A Third

The oncology start-up signed a co-development and commercialization agreement with the French pharmaceutical company for two next-generation EGFR inhibitors.

Deals Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
      • X-ray
  • Other Names / Subsidiaries
    • Dehaier Medical Systems Limited
UsernamePublicRestriction

Register